LUND, Sweden, March 17, 2023 /PRNewswire/ — Immunovia AB (publ) (“Immunovia” or the “Company”) today announces that the prospectus regarding Immunovia’s rights issue (the “Rights Issue”) has been approved and registered by the Financial Supervisory Authority and is available on the…
